More than a billion people taking statins?: Potential implications of the new cardiovascular guidelines

JAMA. 2014 Feb 5;311(5):463-4. doi: 10.1001/jama.2013.284657.

Author

John P A Ioannidis¹

Affiliation

¹ Departments of Medicine and Health Research and Policy, Stanford University School of Medicine2Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, California.

PMID: 24296612
DOI: 10.1001/jama.2013.284657

No abstract available

MeSH terms

Adult
Aged
American Heart Association
Cardiovascular Diseases / prevention & control*
Clinical Trials as Topic
Demography
Drug Industry
Evidence-Based Medicine
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / economics
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Hypercholesterolemia / drug therapy*
Middle Aged
Models, Theoretical
Practice Guidelines as Topic*
Risk Assessment
Societies, Medical
United States / epidemiology

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors